Complement-Mediated Activation of the NLRP3 Inflammasome and Its Inhibition by AAV-Mediated Delivery of CD59 in a Model of Uveitis-Reference-Cited by-同舟云学术

Complement-Mediated Activation of the NLRP3 Inflammasome and Its Inhibition by AAV-Mediated Delivery of CD59 in a Model of Uveitis

Published:2018-06 Issue:6 Volume:26 Page:1568-1580
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Kumar Binit,Cashman Siobhan M.,Kumar-Singh Rajendra

Funder

NIH/NEI

Department of Defense/CDMRP

Ellison Foundation

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference38 articles.

1. Uveitis: a potentially blinding disease;Durrani;Ophthalmologica,2004

2. Pharmacologic treatment of noninfectious uveitis;Knickelbein;Handb. Exp. Pharmacol.,2017

3. Autoimmune uveitis: clinical, pathogenetic, and therapeutic features;Prete;Clin. Exp. Med.,2016

4. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens;Caspi;J. Immunol.,1988

5. Pathology of experimental autoimmune uveoretinitis in mice;Chan;J. Autoimmun.,1990

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retinal Penetrating Adeno-Associated Virus;Investigative Ophthalmology & Visual Science;2024-08-22

2. Targeting inflammasomes and pyroptosis in retinal diseases—molecular mechanisms and future perspectives;Progress in Retinal and Eye Research;2024-07

3. The Complement System as a Therapeutic Target in Retinal Disease;Medicina;2024-06-05

4. The Role of Complement System’s C3 and C4 Fractions in the Pathogenesis of Uveitis;Ocular Immunology and Inflammation;2024-04-08

5. Up-regulation of scleral C5b-9 and its regulation of the NLRP3 inflammasome in a form-deprivation myopia mouse model;Immunobiology;2024-01